San Francisco, California – Immumem Therapeutics, a preclinical-stage biotech company engineering next-generation immune cell therapies for solid tumors, today announced that its founder and CEO, Shubhranshu Gupta, PhD, has been profiled in Unicorns Journal, the founder storytelling platform of Unicorns Club. The feature, titled “Shubh Gupta: Turning Immune Cells into Marathon Runners Against Cancer,” explores … Continue reading Immumem Therapeutics Featured in Unicorns Journal